Related references
Note: Only part of the references are listed.Epidemiological, clinical, and microbiological characteristics of carbapenemase-producing Enterobacteriaceae bloodstream infection in the Republic of Korea
Jung-wan Park et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future
Nicola Petrosillo et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The effect of colistin resistance and other predictors on fatality among patients with bloodstream infections due to Klebsiella pneumoniae in an OXA-48 dominant region
Sirin Menekse et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)
External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance
Isabel Machuca et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
HIGH RATE OF COLISTIN AND FOSFOMYCIN RESISTANCE AMONG CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE IN TURKEY
Serap Suzuk Yildiz et al.
ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA (2019)
Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection
Gregory Saraiva Medeiros et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Hospital Outbreak of a Colistin-Resistant, NDM-1-and OXA-48-Producing Klebsiella pneumoniae: High Mortality from Pandrug Resistance
Huseyin Guducuoglu et al.
MICROBIAL DRUG RESISTANCE (2018)
Colistin resistance in carbapenemase-producing Klebsiella pneumoniae bloodstream isolates: Evolution over 15 years and temporal association with colistin use by time series analysis
Giannoula S. Tansarli et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Impact of the ST101 clone on fatality among patients with colistin-resistant Klebsiella pneumoniae infection
Fusun Can et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Rapid emergence of colistin resistance and its impact on fatality among healthcare-associated infections
M. Aydin et al.
JOURNAL OF HOSPITAL INFECTION (2018)
Could Frequent Carbapenem Use Be a Risk Factor for Colistin Resistance?
Aycan Gundogdu et al.
MICROBIAL DRUG RESISTANCE (2018)
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
Belen Gutierrez-Gutierrez et al.
LANCET INFECTIOUS DISEASES (2017)
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems
Isabel Machuca et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Kiebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates
Konstantina Dafopoulou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study
D. R. Giacobbe et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Carbapenemase-Producing Klebsiella pneumoniae Bloodstream Infections: Lowering Mortality by Antibiotic Combination Schemes and the Role of Carbapenems
George L. Daikos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014
M. Monaco et al.
EUROSURVEILLANCE (2014)
Colistin resistance in Klebsiella pneumoniae
Young-Mi Ah et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Blood stream infections due to OXA-48-like carbapenemase-producing Enterobacteriaceae: treatment and survival
Ilker Inanc Balkan et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
A. Capone et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art
Nicola Petrosillo et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
O. Zarkotou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide Production
Jennifer H. Moffatt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes
May Nguyen et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System
Mark D. Adams et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study
Dimitrios K. Matthaiou et al.
CRITICAL CARE MEDICINE (2008)
Purposeful selection of variables in logistic regression
Zoran Bursac et al.
SOURCE CODE FOR BIOLOGY AND MEDICINE (2008)
Share Paper
